Bakuchi for Anti-Inflammatory

Research suggests that bakuchiol, the primary bioactive compound derived from Psoralea corylifolia (Bakuchi), demonstrates anti-inflammatory properties across multiple lines of evidence, including an in vivo allergic rhinitis model showing reductions in pro-inflammatory cytokines and several narrative and systematic reviews documenting its anti-inflammatory mechanisms in contexts ranging from dermatological applications to organ protection. Studies indicate consistent directional support across all seven identified sources, spanning reviews from 2016 through 2023 and one experimental study from 2024, with none of the available literature reporting neutral or contradictory findings. However, it is worth noting that the evidence base relies heavily on reviews and preclinical or mechanistic research rather than randomized controlled trials or large-scale human clinical studies, which represents a meaningful limitation when assessing how these findings translate to real-world human health outcomes. Readers should interpret current findings as preliminary but directionally consistent, reflecting a need for more rigorous clinical investigation before firm conclusions can be drawn.